Home
Browse
Search
Statistics
About
Usage
PMID: 7525964
Miedzybrodzka ZH, Yin Z, Kelly KF, Haites NE
Evaluation of laboratory methods for cystic fibrosis carrier screening: reliability, sensitivity, specificity, and costs.
J Med Genet. 1994 Jul;31(7):545-50.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
8
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:8:220
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7525964:8:227
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:8:345
status:
NEW
view ABCC7 p.Gly542* details
Standard methods of CF mutation analysis include deletion detection using polyacrylamide gel electrophoresis (PAGE) of PCR product (for example, AF508 and AI507), restriction enzyme digestion ofPCR product (for example,
G551D
,
R553X
, 621 + 1(G-.T)), and probing of PCR product with labelled allele specific oligonucleotides (ASOs) (for example,
G542X
).
Login to comment
12
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:12:79
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:12:194
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:12:383
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:12:86
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:12:201
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:12:393
status:
NEW
view ABCC7 p.Gly542* details
Methods The Cellmark ARMS system tests simultaneously for the mutations AF508,
G551D
,
G542X
, and 621 + 1(G--T).5 PCR is performed in two tubes, one tube containing mutation specific primers for
G551D
,
G542X
, and normal site specific primers for AF508 and 621 + 1(G-+T), the second containing mutation specific primers for AF508 and 621 + 1(G-4T) and normal site specific primers for
G551D
and
G542X
.
Login to comment
19
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:19:141
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7525964:19:187
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 7525964:19:155
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:19:148
status:
NEW
view ABCC7 p.Gly542* details
We chose to evaluate dot blotting by using the Inno-LiPA CF2 kit as an example (Innogenetics).9 This kit detects the mutations AF508, AI507,
G551D
,
G542X
,
N1303K
, W1282Xm 1717-1,G-A, and
R553X
.4 12"1 Mouthwash DNA preparation (5 p1) and Taq polymerase are added to the PCR reagents provided, with biotin dUTP incorporated into PCR product as a label.
Login to comment
26
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:26:143
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:26:133
status:
NEW
view ABCC7 p.Gly542* details
2A + B normal sample: lane A indicates normal sequence at AF508 and 621 + 1, G-T mutation sites, lane B indicates normal sequence at
G542X
and
G551D
mutation sites.
Login to comment
29
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:29:7
status:
NEW
view ABCC7 p.Gly551Asp details
7A + B
G551D
/AF508 compound heterozygote.
Login to comment
30
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:30:7
status:
NEW
view ABCC7 p.Gly542* details
8A + B
G542X
/621 + 1, G-T compound heterozygote.
Login to comment
32
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:32:8
status:
NEW
view ABCC7 p.Gly542* details
12A + B
G542X
carrier.
Login to comment
37
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:37:8
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7525964:37:32
status:
NEW
view ABCC7 p.Arg553* details
Strip 7
G551D
carrier, strip 10
R553X
carrier.
Login to comment
39
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 7525964:39:142
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:39:18
status:
NEW
view ABCC7 p.Gly542* details
Strip 12 is AF508/
G542X
compound heterozygote, 14 is AF508IG551D compound heterozygote, 15 is 1717-1,G--A carrier, 16 is A1507 carrier, 17 is
W1282X
carrier.
Login to comment
40
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 7525964:40:28
status:
NEW
view ABCC7 p.Asn1303Lys details
Strip 18 represents a AF508/
N1303K
compound heterozygote, 19 is no DNA control, 20 is wild type control.
Login to comment
42
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:42:154
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7525964:42:165
status:
NEW
view ABCC7 p.Arg553* details
The third method we evaluated combines deletion analysis with a restriction enzyme digest, allowing simultaneous detection of the mutations AF508, AI507,
G551D
, and
R553X
(deletion/digest/PAGE method).
Login to comment
45
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:45:14
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7525964:45:24
status:
NEW
view ABCC7 p.Arg553* details
The mutations
G551D
and
R553X
destroy a HincII restriction site, AF508 and AI507 cause a smaller band (fig 3).
Login to comment
52
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:52:19
status:
NEW
view ABCC7 p.Gly551Asp details
Lanes 4, 9, and 11
G551D
carriers.
Login to comment
54
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:54:13
status:
NEW
view ABCC7 p.Gly551Asp details
Lane 6 AF508/
G551D
compound heterozygote.
Login to comment
62
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:62:163
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7525964:62:181
status:
NEW
view ABCC7 p.Arg553* details
DELETION/DIGEST/PAGE METHOD This method was used to test DNA from 59 carriers, 58 partners (previously tested negative), and 64 persons affected by CF, for AF508,
G551D
, AI507, and
R553X
.
Login to comment
84
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:84:4
status:
NEW
view ABCC7 p.Gly542* details
The
G542X
mutation specific band appeared, although it was fainter than its control.
Login to comment
85
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:85:165
status:
NEW
view ABCC7 p.Gly542* details
When the test was repeated on two occasions, no mutation specific band was present and direct sequencing confirmed that DNA tested had the wild type sequence at the
G542X
site.
Login to comment
97
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:97:117
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 7525964:97:127
status:
NEW
view ABCC7 p.Gly542* details
About half of the reported failures occurred in the first two tests in a batch, with faint extra bands in the mutant
G551D
and
G542X
positions.
Login to comment
107
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 7525964:107:16
status:
NEW
view ABCC7 p.Gly551Asp details
Two out of nine
G551D
carriers might have been undetected had we relied upon this system alone (two false negatives) and, therefore, although we know that the system works well in other hands, we did not persist with the technique.
Login to comment